Phase II, Double-Blinded, Randomized, Placebo-Controlled Clinical Trial Investigating the Efficacy of Mebendazole in the Management of Symptomatic COVID-19 Patients

• Ngā kaituhi matua: Mohamed El-Tanani (Author), Khaled Abdul-Aziz Ahmed (Author), Ashok K. Shakya (Author), Wesam G. Ammari (Author), Abdel-E (Author)
• Hōputu: Pukapuka
• I whakaputaina: MDPI AG, 2023-05-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

The outbreak of the COVID-19 pandemic has spread throughout the world, affecting almost all nations and territories. The current double-blind, randomized, placebo-controlled, phase II clinical trial sought to evaluate the clinical efficacy and safety of mebendazole as an adjuvant therapy for outpati...